FWIW: Board readers who took survey #127 overwhelmingly thought BMY-MEDX was a better deal for the acquiring company than AMGN-Abgenix and AZN-Cambridge Antibody. If you have already taken the survey, you can view the results at: <a href="http://investorshub.advfn.com/boards/board_survey_results.asp?board_id=1418&Survey_Num=127" rel="nofollow" target="_blank">http://investorshub.advfn.com/boards/board_survey_results.asp?board_id=1418&Survey_Num=127</a>